Our findings suggested that paclitaxel and docetaxel had negative correlations with ELAVL1, HNRNPC and RBM15B, which meant paclitaxel and docetaxel were sensitive to ELAVL1, HNRNPC and RBM15B in LC. Here, RBM15B is linked to laryngotracheoesophageal cleft.